P63 regulates cell proliferation and cell cycle progression-associated genes in stromal cells of giant cell tumor of the bone

International Journal of Oncology

Volumn 42, Issue 2, 2013, Pages 437-443

  Lau, Carol Po Ying ^a   Ng, Patrick Kwok Shing ^b   Li, Man Shan ^b   Tsui, Stephen Kwok Wing ^b   Huang, Lin ^b   Kumta, Shekhar Madhukar ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CDC2; CDC25C; Cell proliferation; Giant cell tumor of bone; P63; SIRNA

Indexed keywords

CDC25C PROTEIN; CYCLIN DEPENDENT KINASE 1; MESSENGER RNA; PROTEIN; PROTEIN P53; PROTEIN P63; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; OSTEOCLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; S PHASE CELL CYCLE CHECKPOINT; STROMA CELL;

BONE NEOPLASMS; CARCINOGENESIS; CDC2-CDC28 KINASES; CDC25 PHOSPHATASES; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; GIANT CELL TUMORS; HUMANS; MEMBRANE PROTEINS; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84873638664     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1727     Document Type: Article

References (31)

1. Goldring SR, Schille AL, Mankin HJ, Dayer JM and Krane SM: Characterization of cells from human giant cell tumors of bone. Clin Orthop Relat Res 204: 59-75, 1986.
2. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ and Papadimitriou JM: The histogenesis of giant cell tumor of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 16: 297-307, 2001.
3. Huang L, Teng XY, Cheng YY, Lee KM and Kumta SM: Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumor cells of giant cell tumor of bone. Bone 34: 393-401, 2004.
4. Sciot R, Dorfman H, Brys P, et al: Cytogenetic-morphologic correlations in aneurismal bone cyst, giant cell tumor of bone and combined lesions. Mod Pathol 13: 1206-1210, 2000.
5. Schwartz HS, Eskew JD and Butler MG: Clonality studies in giant cell tumor of bone. J Orthop 20: 387-390, 2002.
6. Sawyer JR, Goosen LS, Binz RL, Swanson CM and Nicholas RW: Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone. Cancer Genet Cytogenet 159: 32-36, 2005.
7. Forsyth RG, Boeck G, Bekaert S, et al: Telomere biology in giant cell tumour of bone. J Pathol 214: 555-563, 2008.
8. Lee CH, Espinosa I, Jensen KC, et al: Gene expression profiling identified p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol 21: 531-539, 2008.
9. Dickson BC, Li SQ, Wunder JS, et al: Giant cell tumor of bone express p63. Mod Pathol 21: 369-375, 2008.
10. Müller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH and Schilling T: One, two, three-p53, p63, p73 and chemosensitivity. Drug Resist Updat 9: 288-306, 2006.
11. Murray-Zmijewski F, Lane DP and Bourdon JC: p53/p63/p73 isoforms: an orchestra of isoforms to harmonize cell differentiation and response to stress. Cell Death Differ 13: 962-972, 2006.
12. Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R and Guerrini L: Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol Cell Biol 22: 8659-8668, 2002.
13. Mangiulli M, Valletti A, Caratozzolo MF, Tullo A, Sbisà E, Pesole G and D'Erchia AM: Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res 37: 6092-6104, 2009.
14. Moll UM and Slade N: p63 and p73: roles in development and tumor formation. Mol Cancer Res 2: 371-386, 2004.
15. Hermanns P and Lee B: Transcriptional dysregulation in skeletal malformation syndromes. Am J Med Genet 106: 258-271, 2001.
16. Lau CP, Huang L, Tsui SK, Ng PK, Leung PY and Kumta SM: Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. J Orthop Res 29: 403-413, 2011.
17. Wulling M, Delling G and Kaiser E: The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol 34: 983-993, 2003.
18. Robinson D, Segal M and Nevo Z: Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis. Pathobiology 70: 333-342, 2002.
19. Lefkimmiatis K, Caratozzolo MF, Merlo P, et al: p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res 69: 8563-8571, 2009.
20. Malaguarnera R, Mandarino A, Mazzon E, et al: The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer 12: 953-971, 2005.
21. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP and Ellisen LW: p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer cell 9: 45-56, 2006.
22. Sbisà E, Mastropasqua G, Lefkimmiatis K, Caratozzolo MF, D'Erchia AM and Tullo A: Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene. Cell Cycle 5: 205-212, 2006.
23. Crook T, Nicholls JM, Brooks L, O'Nions J and Allday MJ: High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma. Oncogene 19: 3439-3444, 2000.
24. Senoo M, Tsuchiya I, Matsumura Y, et al: Transcriptional dysregulation of the p73L/p63/ p51/p40/KET gene in human squamous cell carcinomas: expression of Delta Np73L a novel dominant-negative isoform and loss of expression of the potential tumor suppressor p51. Br J Cancer 84: 1235-1241, 2001.
25. Hibi K, Trink B, Patturajan M, et al: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462 5467, 2000.
26. Park BJ, Lee SJ, Kim JI, et al: Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60: 3370-3374, 2000.
27. Taniere P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, Scoazec JY and Hainaut P: TP53 mutations amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 85: 721-726, 2001.
28. Zaika AI, Kovalev S, Marchenko ND and Moll UM: Overexpression of the wild-type p73 gene in breast cancer tissues and cell lines. Cancer Res 59: 3257-3263, 1999.
29. Zaika AI, Slade N, Erster SH, et al: DeltaNp73, a dominant negative inhibitor of wild-type p53 and TAp73, is up regulated in human tumors. J Exp Med 196: 765-780, 2002.
30. Tannapfel A, Schmelzer S, Benicke M, et al: Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer. J Pathol 195: 163-170, 2001.
31. Wong KC, Kumta SM, Tse LF, Ng EW and Lee KS: Navigation Endoscopic Assisted Tumor (NEAT) surgery for benign bone tumors of the extremities. Comput Aided Surg 15: 32-39, 2010.